Scancell Holdings doses first patient with second Covid vaccine candidate
It also said no safety concerns emanated from the first group of trial volunteers
Company
Scancell Holdings PLC
LON:SCLP
Scancell is a clinical stage biotech company developing immunotherapies for a cancer-free future by enhancing long-lasting tumour specific immunity. With deep roots in cancer immunology and translational research, the company aims to translate its innovation and creativity to address the need for fast, potent and accessible therapies that are easy to administer in hard-to-treat cancers.
328 stories · page 2 of 4
Scancell Holdings says 16 patients have now been recruited to Covid vaccine trial
The company provided the update alongside its interim results
Proactive news headlines: Scancell, NextEnergy Solar, Seraphim Space, Open Orphan …
A glance at some of the day's highlights from the Proactive Investors newswire.
Scancell Holdings says phase II melanoma trial is underway after recruiting first patient
The company's SCIB1 discovery will be used in combination with checkpoint inhibitor drug Keytruda
Scancell Holdings well-funded to make progress on vaccines, antibodies pipeline
The pharma group will use the capital raised via the issue of shares and convertible loan notes earlier in the financial year to pursue several clinical programmes
Scancell takes new lab and office space in Oxford Science Park to speed clinical trials
Oxford "is the perfect location for Scancell's expansion, with access to an excellent local talent pool as we grow the business", said CEO Lindy Durrant
Scancell receives the green light for cancer vaccine candidate
Chief executive, Professor Lindy Durrant, said: "The approval of the Modi-1 clinical trial application is a significant achievement for the company.”
Scancell Holdings PLC to use needle-free technology for next-generation vaccine candidates
It will use technology pioneered by PharmaJet in the COVIDITY phase I clinical trial
Scancell Holdings says chief scientific officer steps into CEO role
Professor Lindy Durrant, who takes the position with immediate effect, previously served as co-CEO of the firm
Scancell Holdings gets green light for South African COVID-19 trial
The two-part study, which is set to get underway sometime in the second half, will look at both safety and immunogenicity – the ability to provoke an immune response
Archive
Proactive news headlines: Scancell, Advanced Material Development, One Media iP, Cloudbreak Discovery...
A glance at some of the day's highlights from the Proactive Investors newswire
Scancell says preclinical data underlines potential of next-generation vaccine candidate as it prepares for phase I study
“Our next-generation COVID-19 vaccine has the potential to work alongside currently approved vaccines by protecting the population against new variants of SARS-CoV-2," said chief executive, Dr Cliff Holloway
Scancell Holdings assesses development options for cancer immunotherapy after Cancer UK partnership ends
The decision to curtail clinical development work on Scancell target SCIB2 followed a re-assessment of the charity’s collaboration model in the wake of the coronavirus pandemic, the company said
Scancell highlights significantly strengthened cash position
For the six months ended October 31, the developer of immunotherapies said it had ended the period with £25.7mln in cash compared to £3.6mln in April last year, while post-period another £20.5mln had been raised
Juniors make steady progress on COVID-19 programmes while giants grab headlines
Companies in the diagnostics, treatment and vaccines space have posted positive news this week
Scancell Holdings chooses candidate for coronavirus vaccine
As a second-generation vaccine, Scancell believes SN14 offers several potential advantages over currently approved and late-stage vaccines
Scancell beefs up board with medical heavyweights to advance clinical trials
"We are excited by the advice and guidance that Gillies and Robert will be able to provide in advancing these trials and look forward to working with them," said CEO Cliff Holloway
Scancell rearranges general meeting to get loan note approval
The directors said they are aware of a number of shareholders who have indicated that they would vote in favour if more time was available
Scancell is cashed up and looking to extend its capabilities
The company, which has received tremendous support from its shareholders, expects to make further progress in the current year as it looks to broaden the reach of its platforms
Scancell raises £30mln to advance growing pipeline of cancer immunotherapies and COVID-19 vaccine
An additional £3mln open offer will provide existing investors with the chance to acquire new stock in the business
Archive
Proactive news headlines: Scancell, OptiBiotix Health, One Media IP, Brunner Investment Trust...
A glance at some of the day's highlights from the Proactive Investors newswire
Scancell Holdings takes crucial step in Covid vaccine preparations by teaming up with Cobra Biologics
The agreement covers the good manufacturing pracatice (GMP) production of plasmid DNA needed to generate the inoculation against SARS-CoV-2
Scancell Holdings consortium gets government backing for Covid trial
The funding for a team, led by chief scientific officer, Prof Lindy Durrant, is coming from Innovate UK
Scancell completes oversubscribed fundraising to support coronavirus vaccine development
The cash will also be used to support the company's Modi-1 and SCIBI clinical trials
Scancell publishes new research highlighting potential of Modi-1 in hard-to-treat cancers
Scancell is preparing a regulatory submission for a phase I/II clinical study in the UK in the first half of 2021.
Scancell Holdings has AvidiMab paper published in prestigious cancer journal
The paper describes how AvidiMab modifications improve an antibody’s potential therapeutic properties
Small cap movers: Coronavirus crisis shines a light on small-cap pharma
A look back at some of the more interesting stories from London's junior market this week
Archive
Proactive news snapshot: Scancell, SDX Energy, Tekcapital, Genedrive, Inspiration Healthcare …
A glance at some of the day's highlights from the Proactive Investors newswire
Scancell soars as it begins research into coronavirus vaccine
The company is anticipating a phase 1 clinical trial in the first quarter of 2021
Scancell receives US regulatory green light
The US Food & Drug Administration has granted investigational new drug status to the firm's lead drug, SCIB1
Scancell Holdings looks to increase the number of UK phase II trial sites for lead drug
The update was provided alongside the firm’s interim results, which charted a busy period for the immunotherapies specialist, one in which it brought on board a new major shareholder, the Vulpes Life Science Fund
Scancell surges as it inks third collaboration deal for AvidiMab technology
The US firm will conduct preclinical studies to evaluate whether antibodies developed by Scancell's AvidiMab platform can treat cancer
Scancell signs second AvidiMab collaboration, this time in China
This is the company's second research agreement, following the first in September
Scancell Holdings close to securing further patent protection over the IP underpinning its Moditope platform
"The utility of the Moditope technology is increasingly being recognised as a novel and important immuno-therapeutic approach in the treatment of cancer, as evidenced by the expansion of our patent portfolio and selection for presentation o
Scancell Holdings appoints new independent director
Dr Ursula Ney joins the immunotherapies specialist with immediate effect, replacing Dr Matthew Frohn who stands down from end October
Scancell hails first antibody collaboration deal
The company is teaming up with an unnamed "major player" in the world of antibodies
Scancell Holdings lays groundwork for pivotal year
A £3.9mln injection from the life sciences fund Vulpes will effectively bankroll the latest R&D
Archive
Scancell to begin UK arm of phase II skin cancer trial ‘immediately’
Discussions with US regulators have taken longer than expected, so Scancell will now focus its efforts on completing the UK arm of the trial before re-submitting its US application at a later date
Investments and investor services
Renalytix AI gets payment code for its lead product
A look at the day's major movers, including Upland Resources, Mosman, Malvern International, Lekoil, AA, Prospex, Frontier Smart and Future
Archive
Proactive news snapshot: Mosman Oil & Gas, OptiBiotix Health, Highlands Natural Resources …
A glance at some of the day's highlights from the Proactive Investors newswire
Scancell on verge of recruiting patients with advanced melanoma for UK clinical trials
The immunotherapy specialist gave an update on progress for a “busy and productive” half-year.
Investments and investor services
FTSE 100 closes higher as global markets buoyed by US, China talks
The UK's premier share index closed around 73 points higher at 7,499, while FTSE 250 was also up - around 170 points to 19,632
Archive
Proactive news snapshot: Westminster Group, Summit Therapeutics, Ethernity Networks, Hurricane Energy ...
A glance at some of the day's highlights from the Proactive Investors newswire
Investments and investor services
K3 Business bemoans Brexit-related disruption
A look at some of the day's major movers, including Helical, Modern Water, Local Shopping REIT, Team17, TechFinancials, Westminster Group, Verditek and Pelatro
Archive
FTSE 100 closes firmly higher; Ashtead Group top dog
Britain's blue-chip benchmark closed up nearly 86 points at 7,443, while the FTSE 250 added over 154 points at 19,311
Investments and investor services
Maistro shares to become just a blurred memory
A look at the day's major movers, including Great Western Mining, Majestic Wine, Ascent, Ferguson and Just Group
Archive
Proactive news snapshot: Tekcapital, Quadrise Fuels International, Sareum Holdings …
A glance at some of the day's highlights from the Proactive Investors newswire
Scancell raises £3.9mln to advance immunotherapy product pipeline
“At Vulpes we are always searching for overlooked companies that have the ability to make significant advances in medical science, with a view to supporting their development over the long term. We believe Scancell fulfil these criteria per
Archive
Proactive news snapshot: Venn Life Sciences, Berkeley Energia, PowerHouse Energy …
A glance at some of the day's highlights from the Proactive Investors newswire
Immuno-oncology: All you wanted to know but were too afraid to ask
Essentially, immuno-oncology involves developing drugs that use the body’s own immune system to fight cancers
Archive
Proactive news snapshot: WYG, Echo Energy, Collagen Solutions. Bacanora Lithium …
A glance at some of the day's highlights from the Proactive Investors newswire
Investments and investor services
Frontier Smart Technologies soars after rejecting bid approach from Science Group
A look at the day's major movers, including TLOU Energy, Ten Lifestyle, Katoro Gold, Equatorial Palm Oil, Volga Gas, WYG, AB Dynamics and LXI REIT.
Scancell surges after announcing milestone in development of its solid tumours treatment
Scancell has a clinical development partnership with Cancer Research UK, the world's leading cancer charity dedicated to saving lives through research
Investments and investor services
FTSE 100 closes in the red as trade tensions and Brexit confusion rumble on
The UK index of leading shares closed down nearly 38 points at 7,310
Archive
Proactive news snapshot: Symphony Environmental, Oncimmune, Advanced Oncotherapy...
A glance at some of the day's highlights from the Proactive Investors newswire
Scancell adds six ‘world-leading’ cancer specialists to advisory board ahead of Modi-1 trial
“The initial focus of the board will be to inform the clinical strategy for the planned Modi-1 clinical trial and to ensure the best possible outcome in several solid tumour indications”
Archive
Proactive news snapshot: Feedback, BigDish, Scancell, Sirius Minerals …
A glance at some of the day's highlights from the Proactive Investors newswire
Investments and investor services
Sirius Minerals blooms after signing agribusiness deal
A look at the day's major movers, including Image Scan, Water Intelligence, Laura Ashley, Gulf Marine, Synectics and Synnovia
Scancell higher as it is to begin UK arm of phase II skin cancer trial within weeks
The mid-stage study is testing Scancell’s flagship skin cancer immunotherapy in combination with Keytruda – the blockbuster checkpoint inhibitor developed by Merck
Archive
Proactive news snapshot: Anglo Asian Mining, Scancell, Circle Property …
A glance at some of the day's highlights from the Proactive Investors newswire
Investments and investor services
Totally jumps as healthcare provider flags contract awards in upbeat trading statement
A look at some of the day's major movers, including Totally, Ascent Resources , Firestone Diamonds, Adept4, LightwaveRF and Adept4
Scancell Holdings wins Japanese patent protection
It follows on from similar awards in key markets such as the US, Europe, South Africa and Australia
Investments and investor services
WH Ireland claws back some recent losses as shareholders OK fund-raising
A look at the day's major movers, including Cadence Minerals, FW Thorpe, IG Group, LPA, Integrated Diagnostics, Wynnstay and Clear Leisure
Archive
Proactive news snapshot: ValiRx, LoopUp Group, Kibo Energy …
A glance at some of the day's highlights from the Proactive Investors newswire
Archive
FTSE 100 closes higher at traders focus on Federal Reserve's dovish tone
The FTSE 250 though, seen as a better indicator of the state of UK companies, closed down around 41 points at 19,347.
Archive
Proactive news snapshot: Motif Bio, Bluejay Mining, 88 Energy, Scancell …
A glance at some of the day's highlights from the Proactive Investors newswire
Archive
SimplyBiz boosted by agreement to acquire financial adviser Defaqto
A look at the day's biggest risers and fallers including SimplyBiz, Motif Bio, and Amphion
Scancell strengthens IP with two “important” patent grants in US and Europe
The US patent covers Modi-1, while the European patent relates to a monoclonal antibody called FG88
Archive
FTSE 100 closes firmly in red as traders flee risk ahead of Fed statement
The UK blue-chip index finished down nearly 33 points lower at 7,291
Archive
Proactive news snapshot: Faron Pharmaceuticals, Sunrise Resources, Tertiary Minerals …
A glance at some of the day's highlights from the Proactive Investors newswire
PCI-PAL surrenders some recent gains as half-year losses widen
A look at the day's major movers, including Gulf Marine Services, Argos Resources, Premier Technical Services, Serco, Vitec, Purplebricks and Centrica
Scancell in vanguard of immuno-oncology advances, with two technologies that show early promise
The AIM-listed group is at the vanguard of advances in the emerging field of immuno-oncology and is working on two technologies that are showing early promise
Investments and investor services
Philip Hammond’s online tax comments hit ASOS, BooHoo and JustEat
A look at some of the top risers and fallers in London today
Archive
Proactive news snapshot: Arix Bioscience, RM Secured Direct Lending, Diversified Gas & Oil …
A glance at some of the day's highlights from the Proactive Investors newswire
Investments and investor services
FTSE 100 set to end the week in volatility as metal tariffs hit Turkish lira
The quarterly update on the health of the UK economy showed something of a recovery from the snowed under first quarter.
Scancell Holdings part of the new cancer revolution
The AIM-listed drug developer is at the vanguard of advances in the emerging field of immuno-oncology
Investments and investor services
Ascent Resources doubles as it sees end to permitting delays
A look at some of the top risers and fallers in London today
Archive
Proactive news snapshot: Mirada, Touchstone Exploration, Seeing Machines …
A glance at some of the day's highlights from the Proactive Investors newswire
Scancell Holdings extends collaboration with Sweden's Karolinska Institute
The company first teamed up with Sweden's world-leading medical research university two years ago
Archive
Proactive news snapshot: Rockfire Resources, SkinBioTherapeutics, 88 Energy …
A glance at some of the day's highlights from the Proactive Investors newswire
Investments and investor services
NAHL runs into a wall after trading update
Companies covered today include 88 Energy, Bagir Group, Future, Mpac, NAHL, Quadrise Fuels and Smiths Group
Scancell Holdings inks drug delivery technology deal
It has exercised an option on TriGrid, which was developed by Ichor Medical Systems
Investments and investor services
FTSE 100 closes higher, bolstered by sterling's fall; rate rise doubts
The index of leading UK shares closed up just shy of 50 points higher at 7,676, while the FTSE 250 was also up
Archive
Proactive news snapshot: Nektan, i3 Energy, Motif Bio, Amphion Innovations…
A glance at some of the day's highlights from the Proactive Investors newswire
OnTheMarket shares climb above property portal group’s 165p float price for the first time
Some of the main news-driven risers and fallers in London on Wednesday afternoon ...
Scancell receives European patent protection for immunotherapy platform
The patent protects a new class of cancer vaccines rolling off the Moditope platform
Investments and investor services
FTSE 100 closes firmly in red as resource stocks suffer
Global markets are in the red after Donald Trump said he was not happy with the progress of talks with China.
Archive
Proactive news snapshot: Challenger Acquisitions, SDX Energy, Greencoat UK Wind …
A glance at some of the day's highlights from the Proactive Investors newswire
Nanoco Group on the front foot after receiving £1.8mln payment from US partner
A look at some of the top risers and fallers in London on Tuesday
FTSE 100 closes slightly in red; Shire biggest gainer
FTSE 100 closed 1.39 points lower at 7,565, while FTSE 250 went the other way
Archive
Small Cap Movers: No reason for the jump, but Indian online fashion retail Koovs still the week’s biggest riser
A look back at some of the more interesting from the junior market this week
Enteq flows higher as oil sector rebound boosts latest full-year results
Oil prices have recovered over the past year which has led to companies setting up more rigs; good news for Enteq, an oilfield services provider
Archive
Proactive news snapshot: SkinBioTherapeutics, Cradle Arc, HemoGenyx Pharmaceuticals …
A glance at some of the day's highlights from the Proactive Investors newswire
Investments and investor services
IGas Energy advances as Cuadrilla achieves major milestone
A look at some of the biggest risers and fallers in London on Tuesday
Scancell signs manufacturing agreement for its Moditope anti-cancer platform
The AIM-listed firm said its Moditope platform acts by stimulating the production of CD4+ T cells, which seek out and kill tumour cells that would otherwise be hidden from the immune system
Archive
Proactive news snapshot: W Resources, Sunrise Resources, Learning Technologies …
A glance at some of the day's highlights from the Proactive Investors newswire
Elektron Technology shares rise as it sells Queensgate Nano to Prior Scientific
A look at some of today's top risers and fallers in London
Archive
Proactive news snapshot: Scancell Holdings, Mosman Oil And Gas, InnovaDerma …
A glance at some of the day's highlights from the Proactive Investors newswire